Status: current, Defined. Date: 31-Mar 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4356771000168119 | Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) (amlodipine 5 mg + hydrochlorothiazide 12.5 mg + olmesartan medoxomil 40 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4356781000168116 | Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | Is a | olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | Is a | Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has intended active ingredient | olmesartan | true | Inferred relationship | Some | 2121344259 | |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has Australian BoSS | olmesartan medoxomil | true | Inferred relationship | Some | 2121344259 | |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has intended active ingredient | amlodipine | true | Inferred relationship | Some | 1994259403 | |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has Australian BoSS | amlodipine | true | Inferred relationship | Some | 1994259403 | |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has unit of use | tablet | true | Inferred relationship | Some | 1732957975 | |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 1022946722 | |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 1022946722 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet, 10 | has TPUU | True | Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | Inferred relationship | Some | 1314391854 |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet, 10, blister pack | has TPUU | True | Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | Inferred relationship | Some | 1459154574 |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet, 30 | has TPUU | True | Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | Inferred relationship | Some | 149454991 |
| Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet, 30, blister pack | has TPUU | True | Olmesartan/Amlodipine/HCTZ 40/5/12.5 (Apo) tablet | Inferred relationship | Some | 1479825782 |
Reference Sets
Trade product unit of use reference set
FHIR